| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.786 | 0.004 | 0.786 | Antibacterial | 0.752 0.005 DBMET00912 | ||
| 0.701 | 0.008 | 0.701 | Cholesterol antagonist | 0.335 0.071 DBMET00912 | ||
| 0.608 | 0.002 | 0.608 | Aminoacyl-tRNA synthetase inhibitor | 0.481 0.003 DBMET00912 | ||
| 0.598 | 0.016 | 0.598 | Antithrombotic | 0.447 0.038 DBMET00912 | ||
| 0.513 | 0 | 0.513 | Isoleucine-tRNA ligase inhibitor | 0.094 0.001 DBMET00912 | ||
| 0.51 | 0.014 | 0.51 | Hypoglycemic | 0.403 0.027 DBMET00912 | ||
| 0.531 | 0.042 | 0.531 | Cyclophilin D inhibitor | |||
| 0.457 | 0.045 | 0.457 | Immunosuppressant | 0.399 0.063 DBMET00912 | ||
| 0.365 | 0.004 | 0.365 | Farnesoid X receptor antagonist | 0.284 0.007 DBMET00912 | ||
| 0.396 | 0.051 | 0.396 | Immunostimulant | 0.22 0.109 DBMET00912 | ||
| 0.37 | 0.026 | 0.37 | DNA synthesis inhibitor | 0.313 0.039 DBMET00912 | ||
| 0.372 | 0.03 | 0.372 | Hypolipemic | 0.276 0.057 DBMET00912 | ||
| 0.366 | 0.067 | 0.366 | Vasodilator, peripheral | |||
| 0.342 | 0.045 | 0.359 | Sodium/bile acid cotransporter inhibitor | 0.359 0.034 DBMET00912 | DBMET00912 | |
| 0.299 | 0.017 | 0.299 | Protein kinase stimulant | 0.172 0.054 DBMET00912 | ||
| 0.303 | 0.048 | 0.303 | Angiogenesis stimulant | 0.159 0.117 DBMET00912 | ||
| 0.243 | 0.011 | 0.243 | Microtubule formation inhibitor | 0.225 0.015 DBMET00912 | ||
| 0.286 | 0.058 | 0.326 | Platelet antagonist | 0.326 0.044 DBMET00912 | DBMET00912 | |
| 0.301 | 0.073 | 0.301 | Interleukin 2 agonist | 0.28 0.089 DBMET00912 | ||
| 0.266 | 0.047 | 0.266 | Nitric oxide antagonist | 0.225 0.059 DBMET00912 | ||
| 0.298 | 0.087 | 0.298 | Apoptosis antagonist | |||
| 0.211 | 0.019 | 0.231 | Antineoplastic antibiotic | 0.231 0.016 DBMET00912 | DBMET00912 | |
| 0.221 | 0.034 | 0.221 | Interferon gamma antagonist | 0.201 0.04 DBMET00912 | ||
| 0.352 | 0.171 | 0.352 | Antiinflammatory | 0.276 0.238 DBMET00912 | ||
| 0.205 | 0.028 | 0.215 | Arachidonic acid antagonist | 0.215 0.02 DBMET00912 | DBMET00912 | |
| 0.244 | 0.087 | 0.244 | Antioxidant | 0.173 0.139 DBMET00912 | ||
| 0.159 | 0.006 | 0.166 | ATPase (Vacuolar H+) inhibitor | 0.166 0.005 DBMET00912 | DBMET00912 | |
| 0.21 | 0.059 | 0.238 | Hepatoprotectant | 0.238 0.047 DBMET00912 | DBMET00912 | |
| 0.197 | 0.045 | 0.197 | Amylase inhibitor | 0.106 0.091 DBMET00912 | ||
| 0.163 | 0.016 | 0.163 | Selectin antagonist | 0.108 0.025 DBMET00912 | ||
| 0.2 | 0.056 | 0.2 | Lipocortins synthesis antagonist | 0.167 0.084 DBMET00912 | ||
| 0.313 | 0.18 | 0.313 | Caspase 9 stimulant | |||
| 0.171 | 0.055 | 0.182 | Insulin secretagoues | 0.182 0.046 DBMET00912 | DBMET00912 | |
| 0.123 | 0.024 | 0.152 | Phosphofructokinase-1 inhibitor | 0.152 0.018 DBMET00912 | DBMET00912 | |
| 0.114 | 0.02 | 0.114 | Interferon agonist | |||
| 0.118 | 0.027 | 0.118 | Ornithine decarboxylase inhibitor | |||
| 0.091 | 0.004 | 0.091 | Leukotriene B4 receptor 1 antagonist | |||
| 0.119 | 0.032 | 0.252 | ABCA1 expression enhancer | 0.252 0.006 DBMET00912 | DBMET00912 | |
| 0.089 | 0.003 | 0.089 | Leukotriene B4 receptor 2 antagonist | |||
| 0.124 | 0.039 | 0.124 | Toll-Like receptor 4 antagonist | 0.097 0.075 DBMET00912 | ||
| 0.132 | 0.055 | 0.263 | Cholesterol synthesis inhibitor | 0.263 0.016 DBMET00912 | DBMET00912 | |
| 0.271 | 0.194 | 0.317 | Apoptosis agonist | 0.317 0.161 DBMET00912 | DBMET00912 | |
| 0.089 | 0.018 | 0.089 | Interferon inducer | |||
| 0.064 | 0.003 | 0.064 | Prostaglandin F2 alpha agonist | 0.028 0.01 DBMET00912 | ||
| 0.124 | 0.065 | 0.138 | DNA polymerase I inhibitor | 0.138 0.056 DBMET00912 | DBMET00912 | |
| 0.078 | 0.025 | 0.078 | Prostaglandin F2 alpha antagonist | 0.057 0.052 DBMET00912 | ||
| 0.126 | 0.073 | 0.126 | Vanilloid 1 agonist | |||
| 0.065 | 0.015 | 0.065 | Glucose-6-phosphate isomerase inhibitor | 0.06 0.019 DBMET00912 | ||
| 0.208 | 0.161 | 0.208 | Transcription factor NF kappa B inhibitor | |||
| 0.177 | 0.133 | 0.211 | Peptidyltransferase inhibitor | 0.211 0.085 DBMET00912 | DBMET00912 | |
| 0.148 | 0.109 | 0.148 | Phospholipase C inhibitor | |||
| 0.047 | 0.008 | 0.054 | HMG CoA reductase inhibitor | 0.054 0.006 DBMET00912 | DBMET00912 | |
| 0.064 | 0.028 | 0.125 | Protein 50S ribosomal subunit inhibitor | 0.125 0.009 DBMET00912 | DBMET00912 | |
| 0.063 | 0.031 | 0.063 | Lipocortins synthesis agonist | 0.057 0.043 DBMET00912 | ||
| 0.099 | 0.068 | 0.099 | Adenylate kinase inhibitor | |||
| 0.037 | 0.006 | 0.055 | Retinoid X gamma receptor antagonist | 0.055 0.003 DBMET00912 | DBMET00912 | |
| 0.057 | 0.031 | 0.057 | Leukotriene B4 antagonist | |||
| 0.142 | 0.116 | 0.194 | ATPase inhibitor | 0.194 0.043 DBMET00912 | DBMET00912 | |
| 0.093 | 0.072 | 0.093 | Protease inhibitor | |||
| 0.031 | 0.01 | 0.114 | Retinoid X gamma receptor agonist | 0.114 0.003 DBMET00912 | DBMET00912 | |
| 0.039 | 0.019 | 0.06 | Fumarate hydratase inhibitor | 0.06 0.01 DBMET00912 | DBMET00912 | |
| 0.131 | 0.113 | 0.133 | Melanin inhibitor | 0.133 0.109 DBMET00912 | DBMET00912 | |
| 0.082 | 0.066 | 0.082 | Transcription factor NF kappa B stimulant | |||
| 0.1 | 0.083 | 0.115 | Electron transport complex I inhibitor | 0.115 0.054 DBMET00912 | DBMET00912 | |
| 0.032 | 0.019 | 0.033 | Prostaglandin D2 agonist | 0.033 0.018 DBMET00912 | DBMET00912 | |
| 0.032 | 0.02 | 0.032 | Prostaglandin agonist | |||
| 0.064 | 0.054 | 0.064 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.023 | 0.013 | 0.097 | Retinoid X beta receptor agonist | 0.097 0.004 DBMET00912 | DBMET00912 | |
| 0.045 | 0.035 | 0.045 | Microtubule stabilization | |||
| 0.017 | 0.01 | 0.017 | Vitamin D receptor agonist | 0.016 0.014 DBMET00912 | ||
| 0.023 | 0.016 | 0.023 | Purinergic P2Y12 antagonist | |||
| 0.06 | 0.055 | 0.06 | Leukotriene synthesis inhibitor | |||
| 0.016 | 0.011 | 0.016 | Prostacyclin agonist | |||
| 0.057 | 0.053 | 0.057 | Nitric oxide donor | |||
| 0.132 | 0.128 | 0.132 | Platelet adhesion inhibitor | |||
| 0.121 | 0.12 | 0.121 | Growth hormone agonist | |||
| 0.079 | 0.078 | 0.093 | Triose-phosphate isomerase inhibitor | 0.093 0.056 DBMET00912 | DBMET00912 | |
| 0.02 | 0.022 | 0.039 | Retinoic acid receptor agonist | 0.039 0.007 DBMET00912 | DBMET00912 | |
| 0.115 | 0.117 | 0.122 | Thrombolytic | 0.122 0.108 DBMET00912 | DBMET00912 | |
| 0.02 | 0.023 | 0.035 | Retinoic acid gamma receptor agonist | 0.035 0.005 DBMET00912 | DBMET00912 | |
| 0.132 | 0.135 | 0.138 | Anesthetic general | 0.138 0.128 DBMET00912 | DBMET00912 | |
| 0.008 | 0.016 | 0.022 | Antibiotic Macrolide-like | 0.022 0.006 DBMET00912 | DBMET00912 | |
| 0.047 | 0.055 | 0.069 | Prostaglandin EP2 antagonist | 0.069 0.034 DBMET00912 | DBMET00912 | |
| 0.023 | 0.031 | 0.034 | Squalene synthetase inhibitor | 0.034 0.021 DBMET00912 | DBMET00912 | |
| 0.013 | 0.024 | 0.032 | Retinoic acid receptor antagonist | 0.032 0.005 DBMET00912 | DBMET00912 | |
| 0.059 | 0.072 | 0.079 | Na+ K+ transporting ATPase inhibitor | 0.079 0.051 DBMET00912 | DBMET00912 | |
| 0.014 | 0.027 | 0.032 | Retinoic acid alpha receptor antagonist | 0.032 0.005 DBMET00912 | DBMET00912 | |
| 0.015 | 0.033 | 0.023 | Retinoic acid beta receptor agonist | 0.023 0.009 DBMET00912 | DBMET00912 | |
| 0.078 | 0.1 | 0.1 | Expectorant | 0.1 0.069 DBMET00912 | DBMET00912 | |
| 0.03 | 0.053 | 0.056 | Retinoic acid alpha receptor agonist | 0.056 0.01 DBMET00912 | DBMET00912 | |
| 0.007 | 0.042 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.008 DBMET00912 | DBMET00912 | |
| 0.054 | 0.091 | 0.067 | Glutamate dehydrogenase inhibitor | 0.067 0.061 DBMET00912 | DBMET00912 | |
| 0.005 | 0.054 | 0.011 | Retinoic acid beta receptor antagonist | 0.011 0.009 DBMET00912 | DBMET00912 | |
| 0.079 | 0.14 | 0.203 | Alpha-N-acetylglucosaminidase inhibitor | 0.203 0.033 DBMET00912 | DBMET00912 | |
| 0.028 | 0.123 | 0.055 | Aconitate hydratase inhibitor | 0.055 0.032 DBMET00912 | DBMET00912 | |
| 0.113 | 0.238 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.134 0.101 DBMET00912 | DBMET00912 | |
| 0.03 | 0.165 | 0.058 | Transcription factor AP-1 inhibitor | 0.058 0.048 DBMET00912 | DBMET00912 | |
| 0.05 | 0.194 | 0.094 | Anabolic | 0.094 0.071 DBMET00912 | DBMET00912 | |
| 0.072 | 0.35 | 0.148 | Neurotrophic factor enhancer | 0.148 0.141 DBMET00912 | DBMET00912 | |
| 0.024 | 0.395 | 0.094 | GABA C receptor agonist | 0.094 0.074 DBMET00912 | DBMET00912 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |